A reengineered hospital discharge program to decrease rehospitalization: a randomized trial
Brian W Jack, Veerappa K Chetty, David Anthony, Jeffrey L Greenwald, Gail M Sanchez, Anna E Johnson, Shaula R Forsythe, Julie K O'Donnell, Michael K Paasche-Orlow, Christopher Manasseh, Stephen Martin, Larry Culpepper, Brian W Jack, Veerappa K Chetty, David Anthony, Jeffrey L Greenwald, Gail M Sanchez, Anna E Johnson, Shaula R Forsythe, Julie K O'Donnell, Michael K Paasche-Orlow, Christopher Manasseh, Stephen Martin, Larry Culpepper
Abstract
Background: Emergency department visits and rehospitalization are common after hospital discharge.
Objective: To test the effects of an intervention designed to minimize hospital utilization after discharge.
Design: Randomized trial using block randomization of 6 and 8. Randomly arranged index cards were placed in opaque envelopes labeled consecutively with study numbers, and participants were assigned a study group by revealing the index card.
Setting: General medical service at an urban, academic, safety-net hospital.
Patients: 749 English-speaking hospitalized adults (mean age, 49.9 years).
Intervention: A nurse discharge advocate worked with patients during their hospital stay to arrange follow-up appointments, confirm medication reconciliation, and conduct patient education with an individualized instruction booklet that was sent to their primary care provider. A clinical pharmacist called patients 2 to 4 days after discharge to reinforce the discharge plan and review medications. Participants and providers were not blinded to treatment assignment.
Measurements: Primary outcomes were emergency department visits and hospitalizations within 30 days of discharge. Secondary outcomes were self-reported preparedness for discharge and frequency of primary care providers' follow-up within 30 days of discharge. Research staff doing follow-up were blinded to study group assignment.
Results: Participants in the intervention group (n = 370) had a lower rate of hospital utilization than those receiving usual care (n = 368) (0.314 vs. 0.451 visit per person per month; incidence rate ratio, 0.695 [95% CI, 0.515 to 0.937]; P = 0.009). The intervention was most effective among participants with hospital utilization in the 6 months before index admission (P = 0.014). Adverse events were not assessed; these data were collected but are still being analyzed.
Limitation: This was a single-center study in which not all potentially eligible patients could be enrolled, and outcome assessment sometimes relied on participant report.
Conclusion: A package of discharge services reduced hospital utilization within 30 days of discharge.
Funding: Agency for Healthcare Research and Quality and National Heart, Lung, and Blood Institute, National Institutes of Health.
Trial registration: ClinicalTrials.gov NCT00252057.
Figures


Source: PubMed
Közelgő klinikai vizsgálatok
-
University of TennesseeWoodcock Institute for the Advancement of Neurocognitive Research and Applied...Még nincs toborzásMotoros készségek | Egészséges | Végrehajtó funkció
-
University of Texas Southwestern Medical CenterMerck Sharp & Dohme LLCMég nincs toborzásAnális laphámsejtes karcinóma
-
Universita di VeronaAzienda Ospedaliera Universitaria Integrata VeronaMég nincs toborzásRheumatoid arthritis | Degeneratív térdízületi betegségOlaszország
-
University of Wisconsin, MadisonAlkermes, Inc.Még nincs toborzás
-
Virginia Commonwealth UniversityMég nincs toborzás
-
Weill Medical College of Cornell UniversityNational Institute of Mental Health (NIMH); Icahn School of Medicine at Mount SinaiMég nincs toborzásKetamin | fMRI | Depresszió – súlyos depressziós rendellenesség | rTMS | Kezelés-rezisztens depresszió (TRD)Egyesült Államok
-
Weill Medical College of Cornell UniversityBD2 LLCMég nincs toborzásfMRI | Bipoláris zavar (BD) | rTMS | Bipoláris 1 depresszióEgyesült Államok
-
Xentria, Inc.Még nincs toborzás
-
Yale UniversityNational Institute of Mental Health (NIMH)Még nincs toborzás
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeToborzásPheochromocytoma | Pheochromocytoma/Paraganglioma | Pheochromocytoma, metasztatikus | Pheochromocytoma Rosszindulatú | Feochromocytoma és paraganglioma (PPGL)Egyesült Királyság
-
Carl Zeiss Meditec-Dublin CoCeToborzásEpiretinális membrán | Retina betegség | Száraz életkorral összefüggő makuladegeneráció | Vitreoretinális rendellenesség | Macular Abnormalities | Intraretinal Hyporeflective Space | Subretinal Hyporeflective Space | IS/OS (Ellipsoid Zone) Disruption | Retinal Pigment Epithelium (RPE) Elevation | Retinal...Egyesült Államok
-
Celest Therapeutics (Shanghai) Co., Ltd.The First Affiliated Hospital of Anhui Medical UniversityToborzásCLDN18.2 pozitív szilárd daganatokKína